SG171656A1 - Assay for lanthanum hydroxycarbonate - Google Patents

Assay for lanthanum hydroxycarbonate

Info

Publication number
SG171656A1
SG171656A1 SG201103215-8A SG2011032158A SG171656A1 SG 171656 A1 SG171656 A1 SG 171656A1 SG 2011032158 A SG2011032158 A SG 2011032158A SG 171656 A1 SG171656 A1 SG 171656A1
Authority
SG
Singapore
Prior art keywords
assay
lanthanum hydroxycarbonate
hydroxycarbonate
lanthanum
impurity
Prior art date
Application number
SG201103215-8A
Other languages
English (en)
Inventor
Donald Hallenbeck
Simon Bates
Original Assignee
Shire Int Licensing Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Int Licensing Bv filed Critical Shire Int Licensing Bv
Publication of SG171656A1 publication Critical patent/SG171656A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F17/00—Compounds of rare earth metals
    • C01F17/20—Compounds containing only rare earth metals as the metal element
    • C01F17/247—Carbonates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity
SG201103215-8A 2006-05-05 2007-02-01 Assay for lanthanum hydroxycarbonate SG171656A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/418,666 US20070259052A1 (en) 2006-05-05 2006-05-05 Assay for lanthanum hydroxycarbonate

Publications (1)

Publication Number Publication Date
SG171656A1 true SG171656A1 (en) 2011-06-29

Family

ID=38661464

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201103215-8A SG171656A1 (en) 2006-05-05 2007-02-01 Assay for lanthanum hydroxycarbonate

Country Status (15)

Country Link
US (3) US20070259052A1 (no)
JP (1) JP2009536356A (no)
KR (1) KR20090016465A (no)
CN (1) CN101484798A (no)
AU (1) AU2007248374A1 (no)
BR (1) BRPI0710343A2 (no)
CA (1) CA2651344A1 (no)
EA (1) EA200802169A1 (no)
IL (1) IL195051A0 (no)
MA (1) MA31601B1 (no)
MX (1) MX2008014148A (no)
NO (1) NO20085063L (no)
SG (1) SG171656A1 (no)
TW (1) TW200742849A (no)
WO (1) WO2007130721A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
WO2006044657A2 (en) * 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
WO2010106557A2 (en) * 2009-03-20 2010-09-23 Panacea Biotec Limited Stable pharmaceutical formulations comprising anhydrous lanthanum carbonate and process for preparation thereof
BRPI0924533A2 (pt) * 2009-05-15 2015-06-30 Natco Pharma Ltd Processo para a preparação de carbonato de latânio di-hidratado
US8961917B2 (en) 2010-05-12 2015-02-24 Spectrum Pharmaceuticals, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
US8697132B2 (en) 2010-12-01 2014-04-15 Shire Llc Capsule and powder formulations containing lanthanum compounds
US8263119B2 (en) 2010-12-01 2012-09-11 Shire Llc Capsule formulations containing lanthanum compounds
AU2012258249B2 (en) * 2011-05-17 2015-12-10 Zetacube S.R.L Method of detecting polymorphs using synchrotron radiation
US9687574B2 (en) 2011-12-21 2017-06-27 Isotherapeutics Group Llc Radioactive compositions and methods for their therapeutic use
US9575059B2 (en) 2012-06-05 2017-02-21 3M Innovative Properties Company Lanthanum-based concentration agents for microorganisms
CN102671684B (zh) * 2012-06-06 2013-10-30 福州大学 一种复合光催化剂及其制备方法和应用
CN103604820A (zh) * 2013-11-27 2014-02-26 南京钢铁股份有限公司 一种提高xrd实验精度的方法
JP5968401B2 (ja) * 2014-11-12 2016-08-10 三菱重工業株式会社 高温部材の温度推定方法、準安定正方相の含有量測定方法、劣化判定方法
CN110579499A (zh) * 2018-06-08 2019-12-17 北京华睿鼎信科技有限公司 一种碳酸镧或其制剂中碱式碳酸镧杂质的检定方法
CN110095489A (zh) * 2019-05-22 2019-08-06 北京悦康科创医药科技股份有限公司 一种碳酸镧咀嚼片中杂质碱式碳酸镧的定量测定方法
CN111620363A (zh) * 2020-06-13 2020-09-04 南京卡文迪许生物工程技术有限公司 一种四水合碳酸镧的制备方法及其产品
CN113019305B (zh) * 2021-03-03 2021-10-15 重庆三峡学院 多孔碱式碳酸镧磷酸盐吸附剂的制备及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246246A (en) 1977-12-10 1981-01-20 Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry Method for manufacture of hydrated borates
US4592082A (en) * 1984-08-10 1986-05-27 The United States Of America As Represented By The United States Department Of Energy Quantitative determination of mineral composition by powder X-ray diffraction
JPH06705B2 (ja) 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US5045289A (en) 1989-10-04 1991-09-03 Research Corporation Technologies, Inc. Formation of rare earth carbonates using supercritical carbon dioxide
EP0620728B1 (en) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation of tablets of increased strength
JPH06171950A (ja) 1992-12-02 1994-06-21 Shin Etsu Chem Co Ltd ランタンマンガナイト粉末の製造方法
US5562921A (en) * 1994-07-15 1996-10-08 Sherman; Bernard C. Stable solid pharmaceutical compositions containing enalapril maleate
US5435986A (en) * 1994-08-30 1995-07-25 Industrial Technology Research Institute Method for preparing high purity aluminum hydroxide
GB9506126D0 (en) 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
US6281503B1 (en) * 1998-05-06 2001-08-28 Quanta Vision, Inc. Non-invasive composition analysis
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
US6055293A (en) * 1998-06-30 2000-04-25 Seh America, Inc. Method for identifying desired features in a crystal
CN1122702C (zh) 1998-12-29 2003-10-01 中国石油化工集团公司 一种烃类催化裂化硫转移助剂及其使用方法
AUPQ109499A0 (en) 1999-06-21 1999-07-15 Adelaide Brighton Management Limited Sample presentation for x-ray diffraction
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
GB0015745D0 (en) 2000-06-27 2000-08-16 Shire Holdings Ag Treatment of bone diseases
EP1321142A1 (en) 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
US7469036B2 (en) * 2002-04-19 2008-12-23 Los Alamos National Security, Llc Analysis of macromolecules, ligands and macromolecule-ligand complexes
US20040161474A1 (en) 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US6678347B1 (en) 2002-07-26 2004-01-13 Hypernex, Inc. Method and apparatus for quantitative phase analysis of textured polycrystalline materials
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US7256049B2 (en) 2003-09-04 2007-08-14 Tandem Labs Devices and methods for separating phospholipids from biological samples
DE10346433B4 (de) 2003-10-07 2006-05-11 Bruker Axs Gmbh Analytisches Verfahren zum Bestimmen von kristallographischen Phasen einer Messprobe
KR101072196B1 (ko) * 2004-07-27 2011-10-10 샤이어 파마세우티컬, 인크. 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법
WO2006044657A2 (en) 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden

Also Published As

Publication number Publication date
TW200742849A (en) 2007-11-16
US20100092576A1 (en) 2010-04-15
MA31601B1 (fr) 2010-08-02
EA200802169A1 (ru) 2009-06-30
US20070259052A1 (en) 2007-11-08
IL195051A0 (en) 2009-08-03
KR20090016465A (ko) 2009-02-13
WO2007130721A2 (en) 2007-11-15
US20080089948A1 (en) 2008-04-17
NO20085063L (no) 2008-12-04
WO2007130721A3 (en) 2008-04-10
AU2007248374A2 (en) 2008-11-27
CN101484798A (zh) 2009-07-15
US7618656B2 (en) 2009-11-17
MX2008014148A (es) 2009-01-27
CA2651344A1 (en) 2007-11-15
AU2007248374A1 (en) 2007-11-15
JP2009536356A (ja) 2009-10-08
BRPI0710343A2 (pt) 2011-08-09

Similar Documents

Publication Publication Date Title
SG171656A1 (en) Assay for lanthanum hydroxycarbonate
IL205271A0 (en) Immunoassay analysis method
EP2041299A4 (en) METHOD AND COMPOSITIONS FOR DETECTION OF RARE CELLS FROM A BIOLOGICAL SAMPLE
IL192604A (en) Anti-drug antibody assay
EP2146207A4 (en) MEASUREMENT REAGENT, ITS USE IN IMMUNO NEPHELOMETRY, AND ANALYSIS ANALYSIS INSTRUMENT
EP1895136A4 (en) GAS LIQUID SEPARATOR FOR ONE ENGINE
EP2164986A4 (en) ATOMIC FORCE MICROSCOPE AS BIOPUCES ANALYSIS TOOL
EP2082228A4 (en) METHODS AND TESTS FOR DETECTING GP73-SPECIFIC AUTO ANTIBODIES
GB2428871B (en) Device for spectroscopy using charged analytes
SG10201502661SA (en) T cell epitope databases
ZA200708731B (en) Fuel composition for fuel cells
EP1893389A4 (en) DEVICE FOR OPENING ENVELOPES
EP1923943A4 (en) COMPONENT FOR CONSTITUTING A FUEL CELL
EP1956373A4 (en) REAGENT FOR DETERMINING ANTI-PHOSPHOLIPID ANTIBODIES AND REAGENT FOR ASSAYING ANTI-TRÉPONEMA PALLIDUM ANTIBODIES
HK1110386A1 (en) Quantitative assaying method for 3, 5-substituted oxazolidinones
EP2352027A4 (en) METHOD AND REAGENT KIT FOR IMMUNOLOGICAL MEASUREMENT
SI2184605T1 (sl) Imunološki test z dvojnim prepoznavanjem za detekcijo protiteles
EP2088429A4 (en) REAGENT AND METHOD FOR IMMUNOLOGICAL ANALYSIS
GB0604170D0 (en) T cell assays
IL193704A0 (en) Novel assay for the detection of an antibody bound to a cell membrane receptor
ZA200507473B (en) An insert device for culturing cells
PT2062053E (pt) Métodos de imunoensaio melhorados
EP2005163B8 (en) Method for cell based assays
WO2009035357A3 (en) Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method
EP1974213A4 (en) HIGHLY SENSITIVE SECRETAGOGIN ASSAYS AND ITS USE IN DIAGNOSIS AND / OR FORECASTING